Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice

Journal of Physiology

Volumn 575, Issue 2, 2006, Pages 645-656

  Stupka, Nicole ^a   Plant, David R ^a   Schertzer, Jonathan D ^a   Emerson, Tennent M ^a   Bassel Duby, Rhonda ^b   Olson, Eric N ^b   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCINEURIN; CALCINEURIN A; CALCINEURIN A ALPHA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN I; MYOSIN HEAVY CHAIN IIA; UNCLASSIFIED DRUG; UTROPHIN; UTROPHIN A; ISOPROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVATION; FEMALE; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; MALE; MOUSE; MOUSE STRAIN; MUSCLE FIBER MEMBRANE; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE ISOTONIC CONTRACTION; MUSCLE RELAXATION; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SARCOLEMMA; SKELETAL MUSCLE; STRESS STRAIN RELATIONSHIP; TIBIALIS ANTERIOR MUSCLE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL VOLUME; CYTOPLASM; ENZYME ACTIVITY; MDX DYSTROPHIC MOUSE; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE LENGTH; MUSCLE STRETCHING; MUSCLE TETANIC CONTRACTION; PATHOPHYSIOLOGY; PHENOTYPE;

ANIMALS; CALCINEURIN; DYSTROPHIN; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; SIGNAL TRANSDUCTION;

EID: 33747666911     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.108472     Document Type: Article

References (39)

1. Allen DL & Leinwand LA (2002). Intracellular calcium and myosin isoform transitions. Calcineurin and CAM kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem 277, 45323-45330.
2. Allen DL, Sartorius CA, Sycuro LK & Leinwand LA (2001). Different pathways regulate expression of the skeletal myosin heavy chain genes. J Biol Chem 276, 43524-43533.
3. Barton ER, Morris LD, Musaro A, Rosenthal N & Sweeney LH (2002). Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157, 137-147.
4. Bogdanovich S, Krag TOB, Barton-Davis ER, Morris LD, Whittlemore L-A, Ahima RS & Khurana TS (2002). Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418-421.
5. Bulfield G, Siller WG, Wight PAL & Moore KJ (1984). X chromosone linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81, 1189-1192.
6. Chakkalakal JV, Harrison M-A, Carbonette S, Chin ER, Michel RN & Jasmin BJ (2004). Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum Mol Genet 13, 379-388.
7. Chakkalakal JV, Stocksley MA, Harrison M-A, Angus LM, Deschenes-Furry J, St-Pierre SJG, Chin ER, Michel RN & Jasmin BJ (2003). Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling. Proc Natl Acad Sci U S A 100, 7791-7796.
8. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R & Williams SR (1998). A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12, 2499-2509.
9. Deconinck N, Tinsley JM, De Backer F, Fisher R, Kahn D, Phelps S, Davies KE & Gillis JM (1997). Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscle mice. Nat Med 3, 1216-1221.
10. Dellorusso C, Crawford RW, Chamberlain JS & Brooks SV (2002). Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil 22, 467-475.
11. Granata AL, Vecchi C, Graciotti L, Fulgenzi G, Maggi S & Corsi A (1998). Gamma irradiation can reduce muscle damage in mdx dystrophic mice. Acta Neuropathol 96, 564-568.
12. Gregorevic P, Plant DR, Leeding KS, Bach LA & Lynch GS (2002). Improved contractile function of the mdx dystrophic mouse diaphragm muscle following IGF-I administration. Am J Pathol 161, 2263-2272.
13. Griggs RC & Rennie MJ (1983). Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation. Ann Neurol 13, 125-132.
14. Karpati G & Carpenter S (1986). Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am J Med Genet 25, 653-658.
15. -/- mice leads to decreased muscle size in the adult. Dev Biol 232, 115-126.
16. Kissel JT, Burrow KL, Rammohan KW & Mendell JR (2001). Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. Neurology 41, 667-672.
17. Lynch GS, Cuffe SA, Plant DR & Gregorevic P (2001a). IGF-I treatment improves the functional and contractile properties of fast- and slow-twitch skeletal muscle from dystrophic mice. Neuromuscul Disord 11, 260-268.
18. Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV & Faulkner JA (2001b). Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 535, 591-600.
19. Lynch GS, Rafael JA, Chamberlain JS & Faulkner JA (2000). Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am J Physiol Cell Physiol 279, C1290-C1294.
20. Macpherson PC, Schork MA & Faulkner JA (1996). Contraction-induced injury to single fiber segments from fast and slow muscles of rats by single stretches. Am J Physiol Cell Physiol 271, 1438-1446.
21. McKeran RO, Halliday D & Purkiss P (1977). Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in urine. J Neurol Neurosurg Psychiatr 40, 979-981.
22. Matsumura K & Campbell KP (1994). Dystrophin-glycoprotein complex: its role in the pathogenesis of muscular dystrophies. Muscle Nerve 17, 2-15.
23. Nakamura A, Yoshida K, Takeda S, Dohi N & Ikeda S (2002). Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in heart of mdx mice. FEBS Lett 520, 18-24.
24. Nakatani T, Nakashima T, Kita T, Hirofuji C, Itoh K, Itoh M & Ishihara A (1999). Succinate dehydrogenase activities of fibers in the rat extensor digitorum longus, soleus, and cardiac muscles. Arch Histol Cytol 62, 393-399.
25. Naya FJ, Mercer B, Shelton JM, Richardson JA, Williams SR & Olson EN (2000). Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem 275, 4545-4548.
26. O'Keefe S, Tamura J, Kincaid RL, Tocci MJ & O'Neill EA (1992). FK-506- and CsA-sensitive activation of the interleukin-2 promotor by calcineurin. Nature 357, 692-694.
27. Olson EN & Molkentin JD (1999). Prevention of cardiac hypertrophy by calcineurin inhibition: Hope or hype?Circ Res 84, 623-632.
28. Parsons SA, Wilkins BJ, Bueno OF & Molkentin JD (2003). Altered skeletal muscle phenotypes in calcineurin Aα and Aβ gene-targeted mice. Mol Cel Biol 23, 4331-4343.
29. Pasternak C, Wong S & Elson EL (1995). Mechanical function of dystrophin in muscle cells. J Cell Biol 128, 355-361.
30. Petrof BJ, Shrager JB, Stedman HH, Kelly AM & Sweeney HL (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90, 3710-3714.
31. Ryder JW, Bassel-Duby R, Olson EN & Zinrath JR (2004). Skeletal muscle reprogramming by activation of calcineurin improve insulin action on metabolic pathways. J Bioc Chem 278, 44298-44304.
32. Satoru E, Guibinga G-H, Gilbert R, Nalbantoglu J & Petrof BJ (2000). Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiol Genomics 3, 133-144.
33. Schertzer JD, Ryall JG & Lynch GS (2006). Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Am J Physiol Endocrinol Metab in press.
34. Talmadge RJ, Otis JS, Rittler MR, Garcia ND, Spencer SR, Lees SJ & Naya FJ (2004). Calcineurin activation influences muscle phenotype in a muscle-specific fashion. BMC Cell Biol 5, 28.
35. Tinsley J, Deconinck N, Fischer R, Kahn D, Phelps S, Gillis J-M & Davies KE (1998). Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4, 1441-1444.
36. Wehling M, Spencer MJ & Tidball JG (2001). A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155, 123-131.
37. Wu H, Rothermel BA, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio MJ, Olson EN, Bassel-Duby R & Williams SR (2001). Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20, 6414-6423.
38. Zammit PS & Partridge TA (2005). Sizing up muscular dystrophy. Nat Med 8, 1355-1356.
39. Zhang W (2002). Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. Cardiovasc Res 53, 294-303.